Compass Therapeutics, Inc. (NASDAQ:CMPX – Free Report) – Equities research analysts at HC Wainwright boosted their FY2025 earnings per share (EPS) estimates for Compass Therapeutics in a research report issued to clients and investors on Monday, November 10th. HC Wainwright analyst J. Pantginis now forecasts that the company will post earnings per share of ($0.42) [...]
What is HC Wainwright’s Forecast for CMPX FY2025 Earnings?
